Company intelligence / Profile preview

Endoron Medical

Ownership: Private
Development stage: Preclinical

Overview

Endoron Medical’s flagship product, Aortoseal, is currently undergoing an Investigational Device Exemption (IDE)-approved Early Feasibility Study. The device aims to improve outcomes in endovascular aneurysm repair by providing secure, transmural stapling of stent grafts to prevent migration and leaks. No published pivotal or commercial results yet; clinical validation is ongoing

Therapeutic areas: Cardiovascular
Modalities: DeviceCatheter-based deviceStapling device for endograft fixation and sealing
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Aortoseal

Pre-clinical

Indications: Abdominal Aortic Aneurysm

Partnerships

Sofinnova Partners MD Start StrategyEuropean Innovation Council Fund / EIC Accelerator

Beyond the preview

Go deeper on Endoron Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoron Medical.

Explore the full profile